Loading...
Everolimus Plus Octreotide Long-Acting Repeatable in Patients With Colorectal Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT-2 Study
INTRODUCTION. The incidence of colorectal neuroendocrine tumors (NETs) is increasing, and patients with this disease have particularly poor prognoses. Treatment options are limited, and survival times have not improved in the past decade. METHODS. A post hoc analysis of the efficacy and tolerability...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AlphaMed Press
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3556255/ https://ncbi.nlm.nih.gov/pubmed/23263288 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0263 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|